The effect of acotiamide on gastroesophageal reflux events and reflux symptoms in patients with refractory gastroesophageal reflux disease (GERD) who are taking acid suppressive drugs
Phase 4
- Conditions
- Gastroesophageal reflux disease
- Registration Number
- JPRN-UMIN000026364
- Lead Sponsor
- saiseikai nakatsu hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with severe complications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Subject's global assessment of overall treatment efficacy at 2 weeks
- Secondary Outcome Measures
Name Time Method Patients rated of each symptoms at 2 weeks Change of reflux pattern at 2 weeks